DeVinney Erick Wayne

Chief Innovation Officer at AXGN

Sold, on record
$1.1M
Dollars the filings state
Form 4 sales
7
Latest Mar 16, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • AXGNAxogen, Inc.Chief Innovation Officer

Sales by reason

0
Routine
0
Plan not stated
1
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale AXGNPlan not stated
    Dec 21, 2020 2020

    Sold 147 shares at $16.42 ($2k)

    DeVinney Erick Wayne, VP, Clinical&Translational Sc

    Sold 0.2% of holdings ($1M position)62,111 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale AXGNPlan not stated
    Dec 29, 2020 +8 days

    Sold 371 shares at $17.81 ($7k)

    DeVinney Erick Wayne, VP, Clinical&Translational Sc

    Sold 0.6% of holdings ($1.1M position)63,240 shares leftFiling

  3. 3 Form 4 sale AXGNNo plan
    Mar 21, 2024 +1178 days

    Sold 4,578 shares at $7.68 ($35k)

    DeVinney Erick Wayne, Chief Innovation Officer

    No 10b5-1 planSold 2.5% of holdings ($1.4M position)177,474 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale AXGNNo plan
    Mar 19, 2025 +363 days

    Sold 15,111 shares at $17.50 ($264k)

    DeVinney Erick Wayne, Chief Innovation Officer

    No 10b5-1 planSold 6.5% of holdings ($4.1M position)217,762 shares leftFiling

  5. 5 Form 4 sale AXGNNo plan
    Sep 16, 2025 +181 days

    Sold 1,137 shares at $16.29 ($19k)

    DeVinney Erick Wayne, Chief Innovation Officer

    No 10b5-1 planSold 0.5% of holdings ($3.6M position)220,649 shares leftFiling

  6. 6 Form 4 sale AXGNUnusual
    Dec 9, 2025 +84 days

    Sold 19,517 shares at $31.21 ($609k)

    DeVinney Erick Wayne, Chief Innovation Officer

    No 10b5-1 planSold 7.5% of holdings ($8.1M position)241,132 shares left4.3x usual sizeFiling

  7. 7 Form 4 sale AXGNNo plan
    Mar 16, 2026 +97 days

    Sold 5,221 shares at $32.84 ($171k)

    DeVinney Erick Wayne, Chief Innovation Officer

    No 10b5-1 planSold 1.9% of holdings ($8.8M position)262,781 shares left0.5x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (7)

Form 144 notices and Form 4 sales by DeVinney Erick Wayne
Source
Mar 16, 2026Mar 18, 2026AXGNChief Innovation OfficerForm 4 sale5,221$171k1.9%No planSEC
Dec 9, 2025Dec 10, 2025AXGNChief Innovation OfficerForm 4 sale19,517$609k7.5%UnusualSEC
Sep 16, 2025Sep 16, 2025AXGNChief Innovation OfficerForm 4 sale1,137$19k0.5%No planSEC
Mar 19, 2025Mar 19, 2025AXGNChief Innovation OfficerForm 4 sale15,111$264k6.5%No planSEC
Mar 21, 2024Mar 25, 2024AXGNChief Innovation OfficerForm 4 sale4,578$35k2.5%No planSEC
Dec 29, 2020Dec 30, 2020AXGNVP, Clinical&Translational ScForm 4 sale371$7k0.6%Plan not statedSEC
Dec 21, 2020Dec 22, 2020AXGNVP, Clinical&Translational ScForm 4 sale147$2k0.2%Plan not statedSEC